ETF Holdings Breakdown of TXG

TXG institutional holdings

The following institutional investment holdings of TXG have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	73,010	USD 1,218,537 0.6%	16.69
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	20,585 -0.3%	USD 343,564 0.3%	16.69
2025-11-12	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	134,641	USD 2,247,158	16.69
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	74,442	USD 1,242,437	16.69
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	74,442 0.3%	USD 1,242,437 0.9%	16.69
2025-11-12	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	589	USD 9,830 0.6%	16.69
Total =		377,709	USD 6,303,963

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with TXG

TXG Crosses Above Average Analyst Target

In recent trading, shares of 10x Genomics Inc (Symbol: TXG) have crossed above the average analyst 12-month target price of $13.25, changing hands for $13.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valu - 2025-08-05 07:41:55

Back to Listing

Disclaimer